Difficulty: Medium
Average Score: 81%
Practice
Cancer chemotherapy induced vomiting that is not controlled by metoclopramide alone can be suppressed by combining it with
Correct answer
B
Rationale
The correct answer is B) Dexamethasone. Dexamethasone is a corticosteroid that is commonly used to prevent chemotherapy-induced nausea and vomiting, particularly when other antiemetic medications like metoclopramide are not effective on their own. Dexamethasone works by reducing inflammation and suppressing the body's immune response, which can help control nausea and vomiting caused by chemotherapy drugs.
Amphetamine (option A) is a stimulant drug that is not indicated for the treatment of chemotherapy-induced vomiting. Hyoscine (option C) is an anticholinergic medication that is primarily used for motion sickness and gastrointestinal spasms, not specifically for chemotherapy-induced vomiting. Cyclizine (option D) is an antihistamine that is commonly used to treat nausea and vomiting, but dexamethasone is more effective in managing chemotherapy-induced symptoms.
In an educational context, understanding the appropriate use of dexamethasone in managing chemotherapy-induced vomiting is crucial for healthcare professionals involved in oncology care. By knowing the mechanism of action and indications for dexamethasone, they can provide more effective symptom management for cancer patients undergoing chemotherapy, ultimately improving their quality of life during treatment.
Amphetamine (option A) is a stimulant drug that is not indicated for the treatment of chemotherapy-induced vomiting. Hyoscine (option C) is an anticholinergic medication that is primarily used for motion sickness and gastrointestinal spasms, not specifically for chemotherapy-induced vomiting. Cyclizine (option D) is an antihistamine that is commonly used to treat nausea and vomiting, but dexamethasone is more effective in managing chemotherapy-induced symptoms.
In an educational context, understanding the appropriate use of dexamethasone in managing chemotherapy-induced vomiting is crucial for healthcare professionals involved in oncology care. By knowing the mechanism of action and indications for dexamethasone, they can provide more effective symptom management for cancer patients undergoing chemotherapy, ultimately improving their quality of life during treatment.